Changzhou Zhongying Science & Technology Co., Ltd
SZSE:300936.SZ
47.5 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 278.044 | 247.952 | 217.614 | 210.439 | 176.486 | 174.848 | 145.386 | 114.238 | 92.858 | 87.95 |
| Cost of Revenue
| 201.252 | 181.25 | 136.64 | 114.444 | 91.61 | 91.085 | 66.23 | 46.714 | 43.183 | 46.699 |
| Gross Profit
| 76.793 | 66.702 | 80.975 | 95.995 | 84.877 | 83.763 | 79.156 | 67.525 | 49.676 | 41.251 |
| Gross Profit Ratio
| 0.276 | 0.269 | 0.372 | 0.456 | 0.481 | 0.479 | 0.544 | 0.591 | 0.535 | 0.469 |
| Reseach & Development Expenses
| 12.527 | 12.833 | 10.033 | 9.104 | 9.506 | 8.987 | 6.663 | 4.972 | 4.102 | 4.253 |
| General & Administrative Expenses
| 7.981 | 5.413 | 5.284 | 3.709 | -12.662 | -12.755 | -9.354 | 13.782 | 9.376 | 9.385 |
| Selling & Marketing Expenses
| 5.54 | 5.684 | 4.958 | 6.508 | 5.78 | 4.344 | 4.124 | 3.553 | 2.313 | 1.899 |
| SG&A
| 13.521 | 11.097 | 10.243 | 10.217 | -6.882 | -8.411 | -5.23 | 17.335 | 11.689 | 11.284 |
| Other Expenses
| -0.194 | 0.26 | 0 | -0.217 | -3.372 | -3.605 | 3.808 | 0.902 | -0.074 | 0.085 |
| Operating Expenses
| 35.008 | 39.623 | 30.452 | 23.06 | 26.304 | 24.733 | 23.875 | 23.97 | 12.918 | 12.101 |
| Operating Income
| 30.83 | 37.291 | 59.033 | 68.269 | 61.027 | 61.065 | 54.14 | 41.1 | 28.384 | 18.534 |
| Operating Income Ratio
| 0.111 | 0.15 | 0.271 | 0.324 | 0.346 | 0.349 | 0.372 | 0.36 | 0.306 | 0.211 |
| Total Other Income Expenses Net
| 139.801 | 0.26 | 0 | -0.217 | 5.235 | -0.023 | -1.522 | -2.764 | -6.995 | -7.922 |
| Income Before Tax
| 170.631 | 37.551 | 59.033 | 68.052 | 61.037 | 61.041 | 54.172 | 42.002 | 28.31 | 18.619 |
| Income Before Tax Ratio
| 0.614 | 0.151 | 0.271 | 0.323 | 0.346 | 0.349 | 0.373 | 0.368 | 0.305 | 0.212 |
| Income Tax Expense
| 25.364 | 3.115 | 7.306 | 10.274 | 13.332 | 8.291 | 7.562 | 7.967 | 6.751 | 4.762 |
| Net Income
| 146.012 | 34.437 | 51.727 | 57.778 | 47.705 | 52.751 | 46.61 | 34.035 | 21.559 | 13.856 |
| Net Income Ratio
| 0.525 | 0.139 | 0.238 | 0.275 | 0.27 | 0.302 | 0.321 | 0.298 | 0.232 | 0.158 |
| EPS
| 1.94 | 0.46 | 0.69 | 0.77 | 0.63 | 0.95 | 0.89 | 0.65 | 1.36 | 0.87 |
| EPS Diluted
| 1.94 | 0.46 | 0.69 | 0.77 | 0.63 | 0.95 | 0.89 | 0.65 | 1.36 | 0.87 |
| EBITDA
| 200.82 | 62.915 | 73.986 | 77.78 | 67.81 | 67.892 | 62.55 | 51.08 | 42.668 | 34.205 |
| EBITDA Ratio
| 0.722 | 0.254 | 0.34 | 0.37 | 0.384 | 0.388 | 0.43 | 0.447 | 0.459 | 0.389 |